Home
Dashboard
Curated content
Themes

Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council

Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations

Events
Investment heatmap

Matching tool

Powered by

Innovation Radar
dealroom.co

Contact
FAQ
Privacy

Companies
Quince Therapeutics
Team
Team

Quince Therapeutics

Cortexyme is developing novel treatments for altering the course of Alzheimer's and other neurological diseases.

Launch date

2012

Employees

Market cap

-

Enterprise valuation

€276—415m (Dealroom.co estimates May 2018.)

Share price

$0.76 CRTX

South San Francisco California (HQ)

https://quincetx.com/

https://twitter.com/quince_tx https://www.linkedin.com/company/cortexyme-inc.

B2B
health
biotechnology

hard tech
biotechnology
biotech and pharma
neurology
neuroscience

Authorizing premium user...